Haoxi Health plans $4M registered direct offering at $0.40 a share

Haoxi Health Technology Ltd (NASDAQ: HAO) has entered into a definitive agreement with certain investors for a registered direct offering of 10,000,000 Class A Ordinary Shares at $0.40 per share, or pre-funded warrants in lieu thereof, according to a press release from the Beijing-based company.

The aggregate gross proceeds from the offering are expected to be approximately $4 million. The shares carry a par value of $0.32 per share. Pre-funded warrants are priced at the same level as the shares, less an exercise price of $0.33 per share.

The transaction is expected to close on or about July 13, 2026, subject to customary closing conditions. Univest Securities, LLC is acting as the sole placement agent.

The offering is being made pursuant to a shelf registration statement on Form F-3 previously filed with the U.S. Securities and Exchange Commission, which became effective June 13, 2025.

You May Also Be Interested In

• Jupiter Neurosciences prices $2M registered direct offering of shares
• Kairos Pharma announces 1-for-7 reverse stock split
• Singularity Future Technology closes $5M registered direct offering